← Back to patent-cliff list
CAS 2087469-20-1
3-[(4-Methoxyphenyl)methyl]-1,5-dimethyl-2,3,6,7-tetrahydro-1H-azepine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Eptazocine hydrobromide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-[(4-Methoxyphenyl)methyl]-1,5-dimethyl-2,3,6,7-tetrahydro-1H-azepine→3-[(4-Methoxyphenyl)methyl]-1,5-dimethyl-2,3,4,7-tetrahydro-1H-azepine→10-Methoxy-1,4-dimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonine→(1S,6R)-10-Methoxy-1,4-dimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonine→6-[(4-Methoxyphenyl)methyl]-1,4-dimethylazepan-4-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.